Canadian researchers have singled out a peptide known as apelin that could improve survival in CV patients with aortic aneurysms, leading them to dub the molecule the equivalent of insulin for heart disease.

Teva Pharmaceuticals is pulling six bulk lots of its angiotensin II receptor blocker losartan from the market after testing revealed dangerously high levels of N-Nitroso-N-methyl-4-aminobutyric acid, a probable human carcinogen, in the drugs.

Eli Lilly stocks are down 1.4% in premarket trading this week after the company announced the results of its long-awaited REWIND study, Barron’s reported.

The American College of Cardiology is partnering with Chicago-based company Veradigm to assemble the largest-ever ambulatory chronic disease network in the U.S., comprising more than 250,000 clinicians and 100 million patients.

A collaboration between cardiologists and dentists at the Karolinska Institutet in Sweden has linked undetected glucose disorders like diabetes to an increased risk of myocardial infarction and periodontitis, a severe gum disease.

Harvard researchers have identified three health interventions that, if implemented and followed closely over the next quarter-century, could prevent up to 94 million early deaths from noncommunicable diseases like CVD.

Heart patients with untreated white coat hypertension are more than twice as likely to die from cardiovascular disease as their normotensive counterparts, according to a June 11 study.

More than 14 million European adults aged 65 and up will have developed atrial fibrillation by 2060, according to a paper published June 6 in EP Europace.

Mount Sinai Heart announced June 10 that a pair of its top cardiothoracic surgeons succeeded in performing two totally endoscopic coronary arterial bypass surgeries (TECABs) at the end of May, making the hospital the only center in New York State qualified to offer the procedure.

Ultrathin drug-eluting stents performed better than their thicker counterparts in a recent analysis of the BIO-RESORT trial, researchers reported in JAMA Cardiology May 21—but thinner struts might not always be the right go-to for patients after PCI.

An analysis of PARTNER 2 data, published in the June edition of the Journal of the American College of Cardiology, suggests transcatheter aortic valve replacement (TAVR) within failed bioprosthetic surgical aortic valves is a viable long-term solution for high-risk individuals, with patients seeing “excellent” functional and quality of life outcomes three years after the procedure.

A Wisconsin high schooler is speaking up for stroke awareness after she suffered a stroke of her own during gym class, WAOW reported—an event her doctors said was brought on by her birth control pills.